Learn more

FAKULTNI NEMOCNICE HRADEC KRALOVE

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    146,326
  • Filing trend
    ⇧ 500.0%
About

FAKULTNI NEMOCNICE HRADEC KRALOVE has a total of 12 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2014. It filed its patents most often in Czechia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, pharmaceuticals and measurement are FED GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO OBRAZOVANIYA SEVERO-ZAPADNYJ GO, GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO PROFESSIONALNOGO OBRAZOVANIYA SARAT and INNOGENE CO LTD.

Patent filings in countries

World map showing FAKULTNI NEMOCNICE HRADEC KRALOVEs patent filings in countries

Patent filings per year

Chart showing FAKULTNI NEMOCNICE HRADEC KRALOVEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zadak Zdenek 3
#2 Zadák Zdeněk 3
#3 Klemera Petr 3
#4 Adam Tomas 2
#5 Felzmann Adolf 2
#6 Hyšpler Radomír 2
#7 Jun Daniel 2
#8 Gardlo Alzbeta 2
#9 Soukup Ondřej 2
#10 Friedecky David 2

Latest patents

Publication Filing date Title
CZ2019343A3 A toolkit and a tool for removing an angled fragment of a dental instrument from the root channel
CZ2018701A3 Exercise equipment and bed with exercise equipment
CZ2018559A3 Device for measuring muscle strength and a method of testing the muscle performance of athletes
WO2019042488A1 Method of standardized quantification of components of apocrine sweat
CZ2018386A3 1-Alkyl-3- (2-hydroxyethyl) imidazolium halide as a disinfectant and a disinfecting composition containing it
CZ308158B6 2-Morpholino-3,4-dihydroquinazolin-4-one derivative with aromatic substituents at the 8- position, preparation and use
CZ307724B6 A method of diagnosing breast cancer from a sample of apocrine sweat
CZ307756B6 A device with dressing material with adjustable pressure
CZ2014319A3 Process for preparing S-allylthioglutathione, optionally in admixture with S-allyldithioglutathione, mixture of S-allylthioglutathione with S-allyldithioglutathione and S-allyldithioglutathione